Exogenous Reinfection of Tuberculosis in Taiwan
NCT00173433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2014-12-09
Summary
we hypothesize that exogenous reinfection is very important in the Taiwan endemic. Therefore, we design a series of studies to evaluate the individual contribution of exogenous reinfection and endogenous reactivation in the Taiwan endemic, and to realize the impact of exogenous reinfection. First, we will identify the patients with TB relapse after complete treatment. The M. tuberculosis isolates responsible for their initial and recurrent episodes will then be genotyped to clarify the percentage of exogenous reinfection and endogenous reinfection.
Conditions
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Jann-Yuan Wang, MD · National Taiwan University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2006-07-31
- Completion
- 2006-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Serum Inflammatory Marker in Patients With Diagnosis of Nontuberculous Mycobacterial Pulmonary Infection
NCT00942916 ·Status: COMPLETED
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
NCT04433195 ·Status: UNKNOWN ·Phase: NA
-
Integrated Discovery and Development of Innovative TB Diagnostics
NCT06624501 ·Status: COMPLETED
-
Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
NCT01398618 ·Status: UNKNOWN ·Phase: PHASE3
-
Research on New Regimens for Retreatment Pulmonary Tuberculosis
NCT02331823 ·Status: UNKNOWN ·Phase: PHASE4
-
Spatial Epidemiology of Tuberculosis (TB) Infection
NCT00780546 ·Status: UNKNOWN
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study
NCT01182259 ·Status: UNKNOWN
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Role of Genexpert in Extra Pulmonary Tuberculosis
NCT03173261 ·Status: UNKNOWN ·Phase: NA
-
Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease
NCT01680822 ·Status: TERMINATED
-
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
NCT02467608 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
NCT04655794 ·Status: UNKNOWN
-
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis
NCT03423550 ·Status: UNKNOWN
-
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
NCT06875336 ·Status: RECRUITING
-
Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs
NCT00979290 ·Status: COMPLETED
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Diagnosis of Active Tuberculosis by ELISPOT
NCT00174083 ·Status: UNKNOWN
-
A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB
NCT06526039 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
NCT00173264 ·Status: UNKNOWN
-
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
NCT03042754 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sensitivity and Specificity of Xpert MTB/RIF Ultra
NCT06058065 ·Status: NOT_YET_RECRUITING
-
Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India
NCT04342598 ·Status: COMPLETED